Total Payments
$4,315
2024 Payments
$220.18
Companies
22
Transactions
245
Medicare Patients
866
Medicare Billing
$249,532
Payment Breakdown by Category
Food & Beverage$4,315 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,315 | 245 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $745.74 | 51 | $0 (2021) |
| ABBVIE INC. | $526.30 | 29 | $0 (2024) |
| Lundbeck LLC | $524.99 | 27 | $0 (2020) |
| Allergan, Inc. | $523.15 | 39 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $393.41 | 20 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $350.77 | 13 | $0 (2022) |
| Neos Therapeutics, LP | $295.42 | 15 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $158.79 | 7 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $154.33 | 8 | $0 (2020) |
| Shire North American Group Inc | $153.04 | 13 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.18 | 10 | ABBVIE INC. ($220.18) |
| 2023 | $250.66 | 16 | ABBVIE INC. ($250.66) |
| 2022 | $385.17 | 15 | Neurocrine Biosciences, Inc. ($327.60) |
| 2021 | $335.70 | 22 | Takeda Pharmaceuticals U.S.A., Inc. ($316.12) |
| 2020 | $476.14 | 26 | Takeda Pharmaceuticals U.S.A., Inc. ($164.08) |
| 2019 | $1,165 | 68 | Lundbeck LLC ($255.66) |
| 2018 | $718.78 | 40 | Sunovion Pharmaceuticals Inc. ($165.99) |
| 2017 | $763.18 | 48 | Allergan Inc. ($168.86) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 246 | 970 | $140,900 | $69,242 |
| 2022 | 4 | 227 | 905 | $128,020 | $67,844 |
| 2021 | 4 | 199 | 837 | $117,630 | $63,154 |
| 2020 | 4 | 194 | 709 | $106,770 | $49,292 |
Total Patients
866
Total Services
3,421
Medicare Billing
$249,532
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 731 | $109,650 | $53,640 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 190 | $19,000 | $9,409 | 49.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 48 | 49 | $12,250 | $6,194 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 663 | $99,450 | $51,825 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 146 | $14,600 | $7,757 | 53.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 37 | 37 | $9,250 | $5,129 | 55.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 59 | $4,720 | $3,134 | 66.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 672 | $100,800 | $52,846 | 52.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 39 | 126 | $10,080 | $6,616 | 65.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 19 | 19 | $4,750 | $2,690 | 56.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 20 | $2,000 | $1,001 | 50.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 121 | 594 | $89,100 | $40,490 | 45.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 47 | 47 | $11,750 | $5,124 | 43.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 14 | 44 | $3,520 | $2,504 | 71.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 24 | $2,400 | $1,173 | 48.9% |
About Dr. Neda Javaherian, M.D
Dr. Neda Javaherian, M.D is a Psychiatry healthcare provider based in Sherman Oaks, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1922250554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neda Javaherian, M.D has received a total of $4,315 in payments from pharmaceutical and medical device companies, with $220.18 received in 2024. These payments were reported across 245 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,315).
As a Medicare-enrolled provider, Javaherian has provided services to 866 Medicare beneficiaries, totaling 3,421 services with total Medicare billing of $249,532. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Sherman Oaks, CA
- Active Since 10/14/2008
- Last Updated 02/24/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922250554
Products in Payments
- VRAYLAR (Drug) $1,045
- TRINTELLIX (Drug) $574.00
- LATUDA (Drug) $393.41
- INGREZZA (Drug) $350.77
- REXULTI (Drug) $320.55
- Adzenys XR-ODT (Drug) $295.42
- Trintellix (Drug) $220.42
- BRINTELLIX (Drug) $140.76
- VYVANSE (Drug) $136.81
- Vyvanse (Drug) $88.85
- Fanapt (Drug) $81.37
- SUBOXONE SUBLINGUAL FILM (Drug) $78.36
- HETLIOZ (Drug) $77.42
- ABILIFY MYCITE (Drug) $63.07
- VIVITROL (Drug) $47.32
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $44.48
- ABILIFY MAINTENA (Drug) $38.87
- MYDAYIS (Drug) $38.50
- Xyrem (Drug) $35.80
- VNS Therapy (Device) $32.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Sherman Oaks
Martin Schuster, M.d, M.D
Psychiatry — Payments: $1.6M
Psychiatry $1.6M
Thomas Shiovitz, Md, MD
Psychiatry — Payments: $407,824
Psychiatry $407,824
Nitin Nanda, M.d, M.D
Psychiatry — Payments: $90,412
Psychiatry $90,412
Dr. Xue Zhong, Md, MD
Psychiatry — Payments: $44,134
Psychiatry $44,134
Alexander Korchmarev, M.d, M.D
Psychiatry — Payments: $5,419
Psychiatry $5,419
Sepehr Broukhim, D.o, D.O
Psychiatry — Payments: $5,042
Psychiatry $5,042